Nivolumab-induced fulminant type 1 diabetes (T1D): the first Italian case report with long follow-up and flash glucose monitoring
Sign Up to like & getrecommendations! Published in 2018 at "Acta Diabetologica"
DOI: 10.1007/s00592-018-1246-4
Abstract: Nivolumab, an Immune Checkpoint Inhibitor (ICI) against programmed death-1 receptors expressed on T-lymphocytes, has been approved by the Food and Drug Administration (FDA) for the treatment of multiple cancers such as Nonsquamous Cell Lung Cancer… read more here.
Keywords: fulminant type; induced fulminant; first italian; nivolumab induced ... See more keywords
Fulminant type 1 diabetes patients display high frequencies of IGRP-specific type 1 CD8+ T cells.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical immunology"
DOI: 10.1016/j.clim.2021.108893
Abstract: The role of cellular autoimmunity in the pathogenesis of fulminant type 1 diabetes (FT1D) remains largely unknown. In this study, we performed an integrated assay using peripheral blood mononuclear cells to determine the islet antigen-specific… read more here.
Keywords: fulminant type; cd8; frequencies igrp; type diabetes ... See more keywords
The Specialty of Emergency Nurse Practitioner Practice: Erratum.
Sign Up to like & getrecommendations! Published in 2018 at "Advanced Emergency Nursing Journal"
DOI: 10.1097/tme.0000000000000182
Abstract: Barbee, M. S., Ogunniyi, A., Horvat, T., & Dang, T. (2015). Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembroluzimab, and nivolumab in oncology. Annals of Pharmacotherapy, 49(8), 907–937. Bristol-Myers Squibb Company.… read more here.
Keywords: fulminant type; journal; anti; type diabetes ... See more keywords
Glucagon secretions are impaired in patients with fulminant type 1 diabetes
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.13041
Abstract: Arginine‐challenge test in various types of diabetes. read more here.
Keywords: glucagon secretions; fulminant type; impaired patients; type diabetes ... See more keywords
Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.13143
Abstract: We describe here a case of nivolumab‐induced type 1 diabetes, which developed within 9 days of treatment. The case highlights the importance of frequent monitoring of glucose after initiation of nivolumab treatment. read more here.
Keywords: fulminant type; induced fulminant; diabetes precipitous; type diabetes ... See more keywords
Congenital biliary dilatation appearing 3 years after the correction of duodenal atresia with pancreaticobiliary maljunction
Sign Up to like & getrecommendations! Published in 2020 at "Pediatrics International"
DOI: 10.1111/ped.14323
Abstract: 1 Gu Y, Qng Y, Li P et al. Fulminant type 1 diabetes in children: A multicenter study in China. J. Diabetes Res. 2017; 2017: 6924637. 2 Shiga K, Urakami T, Suzuki J et al.… read more here.
Keywords: dilatation appearing; fulminant type; biliary dilatation; type diabetes ... See more keywords
Integrative Analyses of Genes Associated with Fulminant Type 1 Diabetes
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Immunology Research"
DOI: 10.1155/2020/1025857
Abstract: Objective Fulminant type 1 diabetes (FT1D) is a type of type 1 diabetes, which is characterized by rapid onset of disease and severe metabolic disorders. We intend to screen for crucial genes and potential molecular… read more here.
Keywords: fulminant type; network; hub genes; type diabetes ... See more keywords
A case of fulminant type 1 diabetes mellitus, with a precipitous decrease in pancreatic volume, induced by nivolumab for malignant melanoma: analysis of HLA and CTLA-4 polymorphisms
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Dermatology"
DOI: 10.1684/ejd.2016.2923
Abstract: Nivolumab is a monoclonal antibody directed against PD1 (programmed cell death 1) that can improve survival in patients with metastatic melanoma. Such immune checkpoint inhibitors have been known to induce type 1 diabetes mellitus (T1D)… read more here.
Keywords: fulminant type; type diabetes; diabetes mellitus; case fulminant ... See more keywords
Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes
Sign Up to like & getrecommendations! Published in 2019 at "Internal Medicine"
DOI: 10.2169/internalmedicine.2353-18
Abstract: The patient was a 71-year-old woman with aquaporin-4-antibody positive neuromyelitis optica (NMO), with no history of diabetes. On admission, although she showed an extremely elevated plasma glucose level (1,080 mg/dL), her hemoglobin A1c level was… read more here.
Keywords: neuromyelitis optica; type diabetes; fulminant type;
A Patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of Hyperglycemia
Sign Up to like & getrecommendations! Published in 2019 at "Internal Medicine"
DOI: 10.2169/internalmedicine.2780-19
Abstract: A 77-year-old-man with renal cell carcinoma who was undergoing nivolumab treatment visited our department due to hyperglycemia; his plasma glucose level was 379 mg/dL. Although his serum C-peptide immunoreactivity (CPR) level was preserved (5.92 ng/mL),… read more here.
Keywords: fulminant type; level; type diabetes; serum peptide ... See more keywords
Identification of hsa_circRNA_100632 as a novel molecular biomarker for fulminant type 1 diabetes
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1075970
Abstract: Objective Circular RNAs (circRNAs) are associated with diabetes, but their role in fulminant type 1 diabetes (FT1D) is unclear. Thus, we characterized the role of circRNAs in FT1D. Research design and methods CircRNA expression profiles… read more here.
Keywords: hsa circrna; circrna 100632; fulminant type; type diabetes ... See more keywords